The realm of psychedelic experiences continues to captivate researchers, with new studies shedding light on the fascinating neurobiology behind these altered states of consciousness. From the common pathways of psychedelic drugs to the impact of DMT on perception and the memory-enhancing properties of mushrooms, let's embark on a journey through the latest scientific revelations in the world of psychedelics.

Neuralink, the brain-implant company founded by visionary entrepreneur Elon Musk, has reached a significant milestone with the approval of its first-in-human clinical trial by the U.S. Food and Drug Administration (FDA). This breakthrough represents a crucial step forward for Neuralink, following previous challenges in obtaining regulatory clearance for its groundbreaking technology. With the FDA's green light, Neuralink is now one step closer to fulfilling its mission of utilizing brain implants to address a wide range of conditions and potentially unlock extraordinary capabilities such as web browsing and telepathy.